2) Legal Reasoning
A. Why the trial court could decide immunity before the medical-review panel
The Estate’s core procedural argument was that deciding immunity would require deciding medical causation—i.e., whether Elmer died from COVID-19 or from a negligently treated pressure wound—
which would be reserved to the panel. The Court reframed the inquiry: the immunity statutes did not require COVID-19 to be the immediate medical cause of death; they required that the injury
“arise from” COVID-19 or from services/treatment/actions performed for COVID-19. Because the Providers’ assertion of immunity assumes negligence for purposes of the defense
(Putnam Cnty. Sheriff v. Price), the court can accept the Estate’s alleged causal narrative (bed sore led to death) and still decide whether the statutory “arising from” nexus is met.
The decisive move is definitional: the Court treated the immunity question as statutory interpretation applied to largely undisputed timeline and treatment facts.
Under the MMA, issues not requiring expert medical opinion are not “reserved” to the panel (Gierek v. Anonymous 1), so the trial court retained jurisdiction to decide immunity as a threshold matter.
B. State immunity: “arising from COVID-19” includes downstream complications of COVID treatment
The Court applied the text of the Healthcare Immunity Act and the Premises Immunity Act, focusing on statutory definitions of “arising from COVID-19,”
which expressly include harms caused by “services, treatment, or other actions performed for COVID-19.”
Even accepting the Estate’s theory that death resulted from inadequate pressure-wound treatment (rather than from active viral illness), the record—especially the Estate’s own expert—
tied the wound’s development to prolonged immobilization necessary for ventilation due to COVID respiratory failure. That link satisfied the statutes’ required relationship.
In short: if COVID necessitated ventilation, and ventilation/immobilization contributed to the wound, then the wound-related injury “arose from” treatment “performed for COVID-19.”
The Court rejected the Estate’s “he tested negative” argument as legally misdirected: statutory immunity is not limited to injuries caused by viral presence at the moment of death;
it includes injuries stemming from the pandemic response and COVID-directed care.
C. Timing: immunity not defeated merely because death occurred after the state emergency rescinded
The Court disagreed with the Court of Appeals’ view that the Governor’s March 3, 2022 rescission categorically barred Healthcare Immunity Act protection for later care.
Because the relevant services “arose” during and in response to the disaster emergency (treatment began during the emergency; the COVID-necessitated course of care continued),
the Court held that the fact some care extended beyond rescission did not sever immunity. The Court also emphasized that the Premises Immunity Act remained in force for causes of action accruing after March 1, 2020,
and did not expire until 2024.
D. Exceptions: gross negligence and willful/wanton misconduct require designated evidence, not labels
The Court treated the Estate’s invocation of “gross negligence” as insufficient because it was unsupported by designated evidence showing reckless disregard or intentional/conscious wrongdoing
as described in N. Ind. Pub. Serv. v. Sharp and Hershberger v. Brooker. An expert’s criticism that care was “inadequate,” without more,
did not create a triable issue of heightened culpability (consistent with McGowen v. Montes).
E. PREP Act: ventilator use triggers broad federal immunity and preemption
Independently, the Court held the PREP Act barred the claims. The statutory language is expansive: immunity covers claims “caused by, arising out of, relating to,
or resulting from” the administration or use of a covered countermeasure. The Court identified the ventilator as a covered countermeasure and found the Estate’s own expert linked the pressure wound
to immobilization for ventilator support. Citing Cowen v. Walgreen Co., the Court concluded the causal chain could not be separated.
The Court also emphasized the PREP Act’s channeling function: the exclusive remedy is the Covered Countermeasures Process Fund, and the only immunity exception—willful misconduct—
must be brought as an exclusive federal cause of action in the U.S. District Court for the District of Columbia, after pursuing the Fund. Because the Estate did not proceed that way,
the exception did not apply.
3) Impact
A. Procedural impact: earlier dispositive motions in MMA cases involving immunity
The most immediate doctrinal impact is procedural. Waggoner clarifies that Indiana trial courts may decide statutory immunity as a preliminary determination/summary judgment issue
without waiting for a medical-review panel, so long as the immunity question does not require expert opinion. Practically, this invites earlier motions and earlier resolution in cases where
immunity turns on statutory scope and undisputed treatment context.
B. Substantive impact: “arising from COVID-19” is broader than “caused by COVID-19”
Substantively, the Court adopts (and reinforces via Ashley v. Anonymous 1 and Fluhr v. Anonymous Doctor 1) a broad reading of COVID immunity:
harms tied to COVID-directed treatment decisions (ventilation, immobilization, isolation protocols, resource constraints) can qualify even when the immediate injury is non-viral
(pressure wounds, delayed stroke treatment).
This interpretation will likely shape the “nexus” analysis in future cases: litigants should expect courts to examine whether the injury is downstream of COVID-related treatment actions,
not solely whether the patient had COVID at injury/death or whether COVID is the proximate medical cause.
C. Federal overlay: PREP Act as a backstop immunity and preemption tool
The decision underscores that in COVID-era care involving “covered countermeasures,” the PREP Act may independently preempt state-law negligence claims, functioning as a potent backstop even if
state immunity arguments are contested. It also highlights the stringent procedural channeling of willful misconduct claims to federal court in the District of Columbia, which can be outcome-determinative.
D. Litigation strategy and pleading proof burdens
Finally, Waggoner signals that merely pleading “gross negligence” (or raising it late in summary judgment briefing) will not avoid immunity absent designated evidence consistent with
Indiana’s heightened culpability standards. This places greater emphasis on early evidentiary development and on distinguishing negligence from reckless/intentional misconduct.